Menarini Group opens Korean branch

Published: 2013-03-06 06:57:00

Updated: 2013-03-06 06:57:00

Menarini Group, Italy’s leading pharmaceutical company, has recently established its Korean branch to gain a strong foothold in the domestic pharmaceutical market.

The Florence-based Italian multinational company renamed Invida Korea into Menarini Korea as of March 1, following its acquisition...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK